- Home
- Publications
- Publication Search
- Publication Details
Title
Oligonucleotides—A Novel Promising Therapeutic Option for IBD
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-04-24
DOI
10.3389/fphar.2019.00314
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Review article: novel oral-targeted therapies in inflammatory bowel disease
- (2018) J. R. White et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Inflammatory bowel disease: new therapies from antisense oligonucleotides
- (2018) Irene Marafini et al. ANNALS OF MEDICINE
- Oligonucleotide-Based Therapies for Inflammatory Bowel Disease
- (2018) Gerolamo Bevivino et al. BIODRUGS
- Clinical efficacy of the Toll-like receptor 9 agonist cobitolimod using patient-reported-outcomes defined clinical endpoints in patients with ulcerative colitis
- (2018) Raja Atreya et al. DIGESTIVE AND LIVER DISEASE
- Effects of Mongersen (GED-0301) on Endoscopic and Clinical Outcomes in Patients With Active Crohn’s Disease
- (2018) Brian G. Feagan et al. GASTROENTEROLOGY
- Targeting endothelial ligands: (ICAM-1/Alicaforsen, MAdCAM-1)
- (2018) Walter Reinisch et al. Journal of Crohns & Colitis
- ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detections of complications
- (2018) Christian Maaser et al. Journal of Crohns & Colitis
- Understanding and Preventing the Global Increase of Inflammatory Bowel Disease
- (2017) Gilaad G. Kaplan et al. GASTROENTEROLOGY
- Rectal Delivery of a DNAzyme That Specifically Blocks the Transcription Factor GATA3 and Reduces Colitis in Mice
- (2017) Vanessa Popp et al. GASTROENTEROLOGY
- Novel Insights into the Mechanisms of Gut Homing and Antiadhesion Therapies in Inflammatory Bowel Diseases
- (2017) Sebastian Zundler et al. INFLAMMATORY BOWEL DISEASES
- TLR9 Regulates the NF-κB–NLRP3–IL-1β Pathway Negatively inSalmonella-Induced NKG2D-Mediated Intestinal Inflammation
- (2017) Yan Li et al. JOURNAL OF IMMUNOLOGY
- Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
- (2017) Siew C Ng et al. LANCET
- FDA-Approved Oligonucleotide Therapies in 2017
- (2017) Cy A. Stein et al. MOLECULAR THERAPY
- Ameliorating Active Ulcerative Colitis via an Orally Available Toll-Like Receptor-9 Modifier: A Prospective Open-Label, Multicenter Phase II Trial
- (2016) Iris Dotan et al. DIGESTIVE DISEASES AND SCIENCES
- Phase 1 Clinical Study of siRNA Targeting Carbohydrate Sulphotransferase 15 in Crohn’s Disease Patients with Active Mucosal Lesions
- (2016) Kenji Suzuki et al. Journal of Crohns & Colitis
- Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ulcerative Colitis
- (2016) Raja Atreya et al. Journal of Crohns & Colitis
- Th9 cells in inflammatory bowel diseases
- (2016) Benno Weigmann et al. Seminars in Immunopathology
- Loss of Response to Anti-TNFs: Definition, Epidemiology and Management
- (2016) Giulia Roda et al. Clinical and Translational Gastroenterology
- Pivotal Role of Carbohydrate Sulfotransferase 15 in Fibrosis and Mucosal Healing in Mouse Colitis
- (2016) Kenji Suzuki et al. PLoS One
- Development of Fibrosis in Acute and Longstanding Ulcerative Colitis
- (2015) Jessica R. de Bruyn et al. Journal of Crohns & Colitis
- Allergen-Induced Asthmatic Responses Modified by a GATA3-Specific DNAzyme
- (2015) Norbert Krug et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn's Disease
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Review article: anti-adhesion therapies for inflammatory bowel disease
- (2014) T. Lobatón et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Biomarkers can predict potential clinical responders to DIMS0150 a toll-like receptor 9 agonist in ulcerative colitis patients
- (2014) Nikolai V Kuznetsov et al. BMC GASTROENTEROLOGY
- T-Cell Trafficking and Anti-Adhesion Strategies in Inflammatory Bowel Disease: Current and Future Prospects
- (2014) Mahmoud H. Mosli et al. DRUGS
- IL-9 and its receptor are predominantly involved in the pathogenesis of UC
- (2014) Nancy Nalleweg et al. GUT
- GATA3: a master of many trades in immune regulation
- (2014) Yisong Y. Wan TRENDS IN IMMUNOLOGY
- Meta-analysis using individual patient data: efficacy and durability of topical alicaforsen for the treatment of active ulcerative colitis
- (2013) S. Vegter et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Crohn's disease complicated by strictures: a systematic review
- (2013) Florian Rieder et al. GUT
- A phase 1 open-label trial shows that smad7 antisense oligonucleotide (GED0301) does not increase the risk of small bowel strictures in Crohn's disease
- (2012) F. Zorzi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Topical Treatment with the Toll-like Receptor Agonist DIMS0150 Has Potential for Lasting Relief of Symptoms in Patients with Chronic Active Ulcerative Colitis by Restoring Glucocorticoid Sensitivity
- (2012) Eugen Musch et al. INFLAMMATORY BOWEL DISEASES
- Phase I Clinical Trial of Smad7 Knockdown Using Antisense Oligonucleotide in Patients With Active Crohn's Disease
- (2012) Giovanni Monteleone et al. MOLECULAR THERAPY
- Biological Therapy for Ulcerative Colitis: What is after Anti-TNF
- (2011) Gionata Fiorino et al. CURRENT DRUG TARGETS
- Regulation of Homeostasis and Inflammation in the Intestine
- (2011) Thomas T. MacDonald et al. GASTROENTEROLOGY
- Colonic treatments and targets: issues and opportunities
- (2009) Emma L. McConnell et al. JOURNAL OF DRUG TARGETING
- Increased mucosal expression of GATA-3 and STAT-4 in pediatric ulcerative colitis
- (2009) Kiyotaka Ohtani et al. PEDIATRICS INTERNATIONAL
- Leukocyte adhesion molecules in animal models of inflammatory bowel disease
- (2008) Jesús Rivera-Nieves et al. INFLAMMATORY BOWEL DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now